Affiliation:
1. From the Department of Cardiology U.S.L. 17, Ospedale San Pietro Igneo, Fucecchio, Italy
Abstract
The effects of two potent vasodilating drugs, captopril (C) (25 mg tid), nicar dipine (N) (20 mg tid), and placebo (P) were evaluated and compared, in 10 men (mean age of sixty-five years) with intermittent claudication from moderate to severe multilevel chronic occlusive arterial disease (COAD) of the lower extrem ity, by use of the Doppler ultrasonic method, at rest and after Carter's exercise test. All the examined subjects were normotensive, without diabetes or cardio pathy; all have been smokers.The eight-week total protocol consisted of an initial two-week placebo run-in period followed by two active drug phases and a two-week placebo phase, ac cording to a double-blind, randomized, crossover design. At the end of each two-week period, ankle-arm index (AAI) and, following exercise, onset of lower extremity discomfort time (ODT), duration of exercise (ET), decrease of ankle systolic pressure after test (APD), and recovery time (RT) were determined. Moreover, at rest, just after exercise, and after recovery, simultaneous common femoral artery velocity waves were recorded and analyzed by a quantitative approach to detect the peripheral vasomotor adjustments.None of the patients required the withdrawal of the active treatments. Com pared with P, C significantly reduced APD and RT, and N reduced RT and AAI; furthermore N caused a significant decrease in ODT, whereas C showed a trend, although not statistically significant, to increase ODT. Neither active therapy modified ET.These results suggest that C and N have different short-term effects on pe ripheral circulation in COAD. During exercise, C induces hemodynamic im provement in the ischemic lower extremity probably by inhibition of the sympathetic system and consequent reduction in collateral vessel vasoconstric tion.
Subject
Cardiology and Cardiovascular Medicine
Reference40 articles.
1. Juergens JL, Bernatz PE: Arteriosclerosis obliterans. In: Peripheral Vascular Diseases , ed. by Fairbairn JF, Juergens JL, Spittal JA Jr. Philadelphia, WB Saunders, 1979, pp 179-216.
2. Young JR: Diseases of the peripheral arteries. In: The Heart , ed. by Hurst JW. New York, McGraw-Hill, 1986, pp 1339-1346.
3. Coronary Artery Disease in Peripheral Vascular Patients
4. Captopril